|
DNAL1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.294160E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.198430E-01 |
| Normal-vs-Stage2 |
7.734800E-01 |
| Normal-vs-Stage3 |
4.969800E-01 |
| Normal-vs-Stage4 |
5.418300E-02 |
| Stage1-vs-Stage2 |
2.387800E-01 |
| Stage1-vs-Stage3 |
1.531150E-01 |
| Stage1-vs-Stage4 |
7.445600E-02 |
| Stage2-vs-Stage3 |
6.995400E-01 |
| Stage2-vs-Stage4 |
1.515410E-01 |
| Stage3-vs-Stage4 |
4.560600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.500400E-01 |
| Normal-vs-AfricanAmerican |
3.339400E-01 |
| Normal-vs-Asian |
8.881800E-02 |
| Caucasian-vs-AfricanAmerican |
8.662000E-01 |
| Caucasian-vs-Asian |
1.205760E-01 |
| AfricanAmerican-vs-Asian |
5.371700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.858570E-01 |
| Normal-vs-Female |
2.908000E-01 |
| Male-vs-Female |
7.889000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.960400E-01 |
| Normal-vs-Extreme_Weight |
5.456200E-01 |
| Normal-vs-Obese |
1.373610E-01 |
| Normal-vs-Extreme_Obese |
8.358800E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.171600E-01 |
| Normal_Weight-vs-Obese |
1.015010E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.893400E-01 |
| Extreme_Weight-vs-Obese |
4.987000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.572200E-01 |
| Obese-vs-Extreme_Obese |
6.650400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.699400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.125700E-02 |
| Normal-vs-Age(61-80Yrs) |
6.717000E-01 |
| Normal-vs-Age(81-100Yrs) |
4.054000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.369600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.502800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.649800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.920400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.614160E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.422400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.84230000000296E-05 |
| Normal-VS-Type2 PRCC |
4.641500E-03 |
| Normal-VS-KIRP CIMP |
4.244900E-03 |
| Normal-VS-Unclassified PRCC |
6.939000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.0384999767702E-09 |
| Type1 PRCC-VS-KIRP CIMP |
8.04910000000714E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
7.752400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.000600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.122200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.557600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.210200E-02 |
| Normal-vs-N1 |
3.670000E-01 |
| Normal-vs-N2 |
8.45210000000041E-05 |
| N0-vs-N1 |
6.929400E-01 |
| N0-vs-N2 |
1.549630E-01 |
| N1-vs-N2 |
1.042200E-02 |
|
|
